EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Oocyte vitrification reduces blastocyst development but does not compromise chromosomal competence or reproductive and neonatal outcomes in advanced maternal age patients undergoing oocyte accumulation for PGT-A

Stefano Canosa, Danilo Cimadomo, Roberta Maggiulli, Alberto Revelli, Gianluca Gennarelli, Christian Simon Ottolini, Antonio Capalbo, Francesca Bongioanni, Laura Rienzi, Giovanni Coticchio

Reproductive BioMedicine Online · 2026

DOI: 10.1016/j.rbmo.2026.105503 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Reproductive BioMedicine Online, 2026. Verfasst von Stefano Canosa und 9 weiteren Autor:innen. Beteiligte Einrichtung: IVIRMA Global Research Alliance, Genera, Livet, Turin, Italy.. Electronic address: s.canosa88@gmail.com. Hauptthemen laut MEDLINE: Vitrification, Oocytes, Blastocyst, Preimplantation Diagnosis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Does oocyte vitrification affect embryological and reproductive outcomes in women of advanced maternal age undergoing oocyte accumulation for PGT-A? DESIGN: Retrospective observational study (n = 122, mean age: 39.7 ± 2.7 years) undergoing IVF with oocyte accumulation for PGT-A. Each patient contributed vitrified‒warmed cohort (VW) and sibling fresh cohort (F) MII oocytes. The first oocyte cohort was vitrified after the first oocyte retrieval and warmed for insemination alongside fresh oocytes from the second oocyte retrieval. Trophectoderm biopsy and next-generation sequencing-based PGT-A were conducted at the blastocyst stage. Primary outcome was blastocyst formation rate per MII; secondary outcomes were euploidy rate, pregnancy and neonatal outcomes, from the proceeding frozen embryo transfer. RESULTS: Vitrification significantly reduced blastulation rate per MII-allocated oocyte (24.6 ± 34.1% VW versus 44.2 ± 33.9% F; P < 0.0001). Despite lower blastocyst yield, euploidy rates per biopsied blastocyst were comparable (38.8% VW versus 38.0% F; P = 0.91) as were the aneuploidy types. Clinical pregnancy (40.9% VW versus 61.2% F, P = 0.11), miscarriage (11.1% VW versus 10.0% F, P = 0.92) and live birth rates (36.4% VW versus 55.1% F, P = 0.14) per single euploid embryo transfer did not differ. No differences were found in neonatal outcomes, including gestational age, birth weight and sex distribution. CONCLUSIONS: Oocyte vitrification does not affect euploidy rates or chance of live birth per euploid embryo transfer. The reduction in blastocyst yield observed in older patients indicates that this population should be appropriately counselled about the potential effect on embryo availability and cumulative outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitrificationOocytesBlastocystPreimplantation DiagnosisCryopreservationHumansFemaleAdultPregnancyRetrospective StudiesAdvanced Maternal AgeEmbryo TransferPregnancy RateFertilization in VitroPregnancy OutcomeMaternal AgeOocyte Retrieval

Stichwörter der Autor:innen

IVFPGT-Aembryo competenceoocyte accumulationoocyte vitrification

Autor:innen und Institutionen

  • IVIRMA Global Research Alliance, Genera, Livet, Turin, Italy.. Electronic address: s.canosa88@gmail.com.
  • IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.; Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.
  • IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
  • IVIRMA Global Research Alliance, Genera, Livet, Turin, Italy.; Obstetrics and Gynecology 2U, Department of Surgical Sciences, City of Health and Science, S. Anna Hospital, University of Turin, Turin, Italy.
  • IVIRMA Global Research Alliance, Genera, Livet, Turin, Italy.; Obstetrics and Gynecology 1U, Physiology of Reproduction and IVF Unit, Department of Surgical Sciences, City of Health and Science, S. Anna Hospital, Univer…
  • Juno Genetics, Rome, Italy.; University College London Institute for Women's Health, Department of Maternal and Fetal Medicine, London, UK.

Zitieren

APA

Canosa, S., Cimadomo, D., Maggiulli, R., Revelli, A., Gennarelli, G., Ottolini, C. S., Capalbo, A., Bongioanni, F., Rienzi, L., & Coticchio, G. (2026). Oocyte vitrification reduces blastocyst development but does not compromise chromosomal competence or reproductive and neonatal outcomes in advanced maternal age patients undergoing oocyte accumulation for PGT-A. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2026.105503

Vancouver

Canosa S, Cimadomo D, Maggiulli R, Revelli A, Gennarelli G, Ottolini CS, et al. Oocyte vitrification reduces blastocyst development but does not compromise chromosomal competence or reproductive and neonatal outcomes in advanced maternal age patients undergoing oocyte accumulation for PGT-A. Reproductive BioMedicine Online. 2026. doi:10.1016/j.rbmo.2026.105503

BibTeX
@article{Canosa2026,
  author = {Canosa, Stefano and Cimadomo, Danilo and Maggiulli, Roberta and Revelli, Alberto and Gennarelli, Gianluca and Ottolini, Christian Simon and Capalbo, Antonio and Bongioanni, Francesca and Rienzi, Laura and Coticchio, Giovanni},
  title = {Oocyte vitrification reduces blastocyst development but does not compromise chromosomal competence or reproductive and neonatal outcomes in advanced maternal age patients undergoing oocyte accumulation for PGT-A},
  journal = {Reproductive BioMedicine Online},
  year = {2026},
  doi = {10.1016/j.rbmo.2026.105503}
}
Kostenlos starten →